{"disease":{"id":"high-risk-large-b-cell-lymphoma-lbcl","name":"high risk large b cell lymphoma lbcl"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06935136","title":"Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Ruijin Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}